钩藤总生物碱干预高血压血管重塑及保护血管内皮细胞功能的研究
|
摘要
本实验为山东省教育厅课题：课题编号-J05L05。
目的：研究表明,原发性高血压与内皮细胞功能障碍有关。理想的抗高血压药物除降低血压外,还应具有改善高血压血管结构和功能,逆转动脉重塑,保护内皮细胞功能和保护靶器官的作用。钩藤为临床治疗高血压病的常用药物,钩藤的有效组分钩藤总生物碱有高生物活性,有较好的降压作用,其降压机制尚不明确。以往研究表明钩藤总生物碱通过抗高血压血管重塑、抑制血管平滑肌细胞增殖的途径来降血压,通过抑制内皮细胞衰老降压这一领域尚未涉及。本研究通过探索钩藤总生物碱抗高血压血管重塑、保护内皮细胞结构功能、抑制血管内皮细胞衰老的作用及其机制,试图开辟其抑制内皮细胞衰老----保护内皮细胞功能—逆转血管重塑—降低血压、保护靶器官这一防治高血压的新途径。
方法：在体实验以自发性高血压大鼠(SHR)为模型,观察钩藤总生物碱对SHR尾动脉血压的影响；对大鼠胸主动脉、肠系膜动脉组织学和体视学变化的影响；对大鼠胸主动脉内皮超微结构的影响；对大鼠胸主动脉内皮β-半乳糖苷酶表达和端粒酶活性相对表达量的影响。以研究钩藤总生物碱降血压、改善血管重塑的效果及可能的机制。离体实验分别建立培养以AngⅡ诱导增殖和D-半乳糖诱导衰老的大鼠胸主动脉内皮细胞(RAEC)模型,MTT法观察钩藤总生物碱对RAEC增殖活度的影响；免疫组织化学法观察其对RAEC Ca2+浓度相对表达值的影响；流式细胞仪观察其对RAEC细胞周期的影响；扫描电镜观察其对RAEC超微结构的影响；β-半乳糖苷酶染色显示其对RAEC衰老阳性率的影响；PCR-ELISA法检测其对RAEC端粒酶活性的影响；流式细胞仪观察其对衰老RAEC凋亡的影响,以研究钩藤总生物碱抑制AngⅡ诱导的RAEC增殖、抑制D-半乳糖诱导的RAEC衰老及其促衰老RAEC凋亡的作用及可能机制。
结果：在体实验表明钩藤总生物碱可以降低SHR尾动脉血压,与模型组相比有非常明显差异(P<0.01)；钩藤总生物碱组大鼠胸主动脉、肠系膜动脉中膜厚度／管腔直径的比值与模型组比较均明显降低(P<0.05)；各组胸主动脉内皮扫描电镜观察结果与模型组比较,钩藤总生物碱组内皮形态结构均有明显改善,表现在内皮细胞排列整齐,表面光滑,内皮细胞脱落明显减少,内膜损伤明显减轻；钩藤总生物碱组大鼠胸主动脉内皮β-半乳糖苷酶表达与模型组比较均明显降低(P<0.05)；钩藤总生物碱组大鼠胸主动脉内皮端粒酶活性相对表达量与模型组比较均明显降低(P<0.05)。离体实验：MTT实验表明血管紧张素Ⅱ具有明显促进RAEC增殖作用,钩藤总生物碱能抑制血管紧张素Ⅱ诱导的RAEC增殖；钩藤总生物碱组RAEC Ca2+浓度相对表达值明显降低(P<0.05)；细胞周期研究发现钩藤总生物碱组与诱导增殖组相比,G1期增高(P<0.05),S期明显降低(P<0.01),可见钩藤总生物碱可以阻断细胞由Go／Gl期向DNA合成的S期转化,从而抑制培养的RAEC衰老的作用；RAEC超微结构电镜扫描表明与D-gal诱导衰老组比较,钩藤总生物碱组的RAEC形态结构如细胞形态、大小及微绒毛数量、分布均有明显改善；β-半乳糖苷酶染色表明,D-半乳糖具有明显诱导RAEC衰老的作用,钩藤总生物碱组β-半乳糖苷酶表达的衰老细胞阳性率较D-半乳糖诱导衰老组非常明显降低(P<0.01)；钩藤总生物碱组端粒酶活性检测与模型组比较均明显降低(P<0.05)；钩藤总生物碱可以显著促进衰老内皮细胞的凋亡(P<0.05)。
结论：研究表明钩藤总生物碱可以显著降低SHR尾动脉血压,有明显的降血压的作用；具有明显的改善、逆转高血压血管重塑的效应；具有明显改善血管内皮结构和功能,保护血管内皮的功能；具有明显抑制血管内皮衰老的作用。钩藤总生物碱可抑制AngⅡ的促RAEC增殖效应,对D-半乳糖介导的RAEC衰老具有明显的抑制作用,可明显改善RAEC结构和功能,降低衰老细胞阳性率和端粒酶活性,有显著的抑制RAEC衰老的作用,有明显的促进衰老的RAEC凋亡的作用。
This experiment had come from shandong provincial projects:topic Numbers--J05L05.
Objective:The recent studies indicate that, primary hypertension pertains to endothelial function obstacle. The ideal antihypertensive medication besides lower blood pressure, still should improve the structure and function of the vascular hypertension, reverse arterial remodeling, and make the function of normal, protect endothelial function and protection of target organs. The Uncaria rhynchOphylla is commonly used medicine for clinical treatment of hypertension. The effective components of the Uncaria rhynchOphylla total alkaloids have high biological activity, having good step-down, resisting myocardial reconstruction and antiarrhythmic effect, but the hypotensive mechanism is unclear. Previous research shows that, total alkaloids lower blood pressure through antihypertensive vascular remodeling, inhibit antihypertensive vascular smooth muscle cell proliferation. The field Inhibiting endothelial cell ageing step-down has not involved. Therefore, this research explored the function and mechanism of the Uncaria rhynchOphylla that antihypertensive vascular remodeling, inhibit endothelial cell aging. And try to open up its by inhibiting endothelial cell senescence-to protect endothelial cell function-reverse the vascular remodeling-lower blood pressure-protect the target organs, an effective way to control the field of hypertension.
Methods:In vivo experiments, we took spontaneously hypertensive rats (SHR) as a model. Then we observed the influence of Uncaria alkaloids on the blood pressure of SHR tail artery, on the rat thoracic aorta, mesenteric artery histological and stereological changes, on the rat aorta endothelial ultrastructure, on the Rat aortic endothelialβ-galactosidase expression and telomerase activity expression of the relative. On this basis, we study the effect and possible mechanism of Uncaria rhynchOphylla total alkaloids step-down, improve the effect of vascular remodeling. In vitro experiments, we build RAEC model AngⅡinduced by the proliferation and D-galacitiol induced agingl respectively. We observed the effects of total alkaloid on RAEC proliferation activity by MTT method, on RAEC Ca2+concentration the value of the relative expression by immunohistochemistry, on RAEC group cell cycle By flow cytometry, on RAEC ultrastructure by scanning electron microscopy,on positive rate of aging RAEC byβ-galactosidase staining, on the expression of telomerase activity in RAEC by PCR-ELISA assay and on the apoptosis of aging RAEC. To study the effect and the possible mechanism of Uncaria rhynchOphylla total alkaloids that AngⅡRAEC induced by inhibiting proliferation, restrain D-galacitiol RAEC induced aging and promote aging RAEC apoptosis.
Results:The vivo experiments show that RTA can reduce the total alkaloid SHR tail arterial blood pressure and has very obvious difference compared with the model group(P<0.01). Comparing with the model group, the RTA group, mesenteric artery and the thoracic aorta film thickness/lumen diameter ratio reduced significantly(P<0.05). The results of thoracic aortic endothelial scanning electron microscope shows that the RTA group s endothelial form structure were obviously improvedCompared comparing with the model group. It performances that endothelial cells aligned with a smooth surface, the cell shedding reduced obviously and lining damage ligtening obviously. The thoracic aortic endothelial rats beta galacitiol nucleoside enzyme expression of the RTA group reduced significantly compareing with the model group (P <0.05). AT the same time, the thoracic aortic endothelial rats relative express telomerase activity of the RTA group reduced significantly compareing too with the model group (P<0.05). The vitro experiments indicate that:The MTT experiments showed thatⅡangiotensin significantly promote RAEC proliferation, the Total alkaloid can inhibit the proliferation of angiotensinⅡ-induced RAEC, the RAEC Ca2+concentration of the RTA group significantly reduce relative to express (P<0.05), It was found that G1 period became high (P<0.05) and S period became lower (P<0.01) in the RTA group, and the RTA blocked the transform from G0/G1 period to synthesis of DNA period, so that theRAEC proliferation was inhibited. RAEC ultrastructure scanning electrometry microscopy showed that the RAEC morphological structure of the RTA group improved obviously, such as the cell morphology and size and microvilli quantity and distribution. Beta galacitiol nucleoside enzymes stain shows that D-galacitiol has obvious effect of RAEC induced aging, the rate of senescent cells of the RTA group reduced obviously (P<0.01). Detection of telomerase activity were significantly lower compareing with the model group (P<0.05). The RTA can improve senescence endothelial cell apoptosis significantly(P<0.05).
Conclusion:This medicine opened a new field for traditional Chinese medicine to control of hypertension,though the effective way that inhibitting endothelial cells-protecting endothelial function-reversing vascular remodeling-reducing blood pressure-protecting target organs. Research shows that RTA can significantly reduce the total alkaloid SHR tail arterial blood pressure.It has an significant function to lower blood pressure. The RTA has the obvious improvement, vascular remodeling of reverse hypertension. It can improve sendothelial function and structure and protect endothelial function and inhibit endothelial function of aging significantly. The RTA can inhibit Ang II RAEC proliferation-promoting effect. For D-galacitiol mediated RAEC aging has obvious inhibition. The RTA can obviously improve the structure and function of the RAEC. The RTA can reduce positive senescent cells and the telomerase activity. The RTA can inhibit the RAEC aging significantly. The RTA can improve senescence endothelial cell apoptosis significantly.
目的：研究表明,原发性高血压与内皮细胞功能障碍有关。理想的抗高血压药物除降低血压外,还应具有改善高血压血管结构和功能,逆转动脉重塑,保护内皮细胞功能和保护靶器官的作用。钩藤为临床治疗高血压病的常用药物,钩藤的有效组分钩藤总生物碱有高生物活性,有较好的降压作用,其降压机制尚不明确。以往研究表明钩藤总生物碱通过抗高血压血管重塑、抑制血管平滑肌细胞增殖的途径来降血压,通过抑制内皮细胞衰老降压这一领域尚未涉及。本研究通过探索钩藤总生物碱抗高血压血管重塑、保护内皮细胞结构功能、抑制血管内皮细胞衰老的作用及其机制,试图开辟其抑制内皮细胞衰老----保护内皮细胞功能—逆转血管重塑—降低血压、保护靶器官这一防治高血压的新途径。
方法：在体实验以自发性高血压大鼠(SHR)为模型,观察钩藤总生物碱对SHR尾动脉血压的影响；对大鼠胸主动脉、肠系膜动脉组织学和体视学变化的影响；对大鼠胸主动脉内皮超微结构的影响；对大鼠胸主动脉内皮β-半乳糖苷酶表达和端粒酶活性相对表达量的影响。以研究钩藤总生物碱降血压、改善血管重塑的效果及可能的机制。离体实验分别建立培养以AngⅡ诱导增殖和D-半乳糖诱导衰老的大鼠胸主动脉内皮细胞(RAEC)模型,MTT法观察钩藤总生物碱对RAEC增殖活度的影响；免疫组织化学法观察其对RAEC Ca2+浓度相对表达值的影响；流式细胞仪观察其对RAEC细胞周期的影响；扫描电镜观察其对RAEC超微结构的影响；β-半乳糖苷酶染色显示其对RAEC衰老阳性率的影响；PCR-ELISA法检测其对RAEC端粒酶活性的影响；流式细胞仪观察其对衰老RAEC凋亡的影响,以研究钩藤总生物碱抑制AngⅡ诱导的RAEC增殖、抑制D-半乳糖诱导的RAEC衰老及其促衰老RAEC凋亡的作用及可能机制。
结果：在体实验表明钩藤总生物碱可以降低SHR尾动脉血压,与模型组相比有非常明显差异(P<0.01)；钩藤总生物碱组大鼠胸主动脉、肠系膜动脉中膜厚度／管腔直径的比值与模型组比较均明显降低(P<0.05)；各组胸主动脉内皮扫描电镜观察结果与模型组比较,钩藤总生物碱组内皮形态结构均有明显改善,表现在内皮细胞排列整齐,表面光滑,内皮细胞脱落明显减少,内膜损伤明显减轻；钩藤总生物碱组大鼠胸主动脉内皮β-半乳糖苷酶表达与模型组比较均明显降低(P<0.05)；钩藤总生物碱组大鼠胸主动脉内皮端粒酶活性相对表达量与模型组比较均明显降低(P<0.05)。离体实验：MTT实验表明血管紧张素Ⅱ具有明显促进RAEC增殖作用,钩藤总生物碱能抑制血管紧张素Ⅱ诱导的RAEC增殖；钩藤总生物碱组RAEC Ca2+浓度相对表达值明显降低(P<0.05)；细胞周期研究发现钩藤总生物碱组与诱导增殖组相比,G1期增高(P<0.05),S期明显降低(P<0.01),可见钩藤总生物碱可以阻断细胞由Go／Gl期向DNA合成的S期转化,从而抑制培养的RAEC衰老的作用；RAEC超微结构电镜扫描表明与D-gal诱导衰老组比较,钩藤总生物碱组的RAEC形态结构如细胞形态、大小及微绒毛数量、分布均有明显改善；β-半乳糖苷酶染色表明,D-半乳糖具有明显诱导RAEC衰老的作用,钩藤总生物碱组β-半乳糖苷酶表达的衰老细胞阳性率较D-半乳糖诱导衰老组非常明显降低(P<0.01)；钩藤总生物碱组端粒酶活性检测与模型组比较均明显降低(P<0.05)；钩藤总生物碱可以显著促进衰老内皮细胞的凋亡(P<0.05)。
结论：研究表明钩藤总生物碱可以显著降低SHR尾动脉血压,有明显的降血压的作用；具有明显的改善、逆转高血压血管重塑的效应；具有明显改善血管内皮结构和功能,保护血管内皮的功能；具有明显抑制血管内皮衰老的作用。钩藤总生物碱可抑制AngⅡ的促RAEC增殖效应,对D-半乳糖介导的RAEC衰老具有明显的抑制作用,可明显改善RAEC结构和功能,降低衰老细胞阳性率和端粒酶活性,有显著的抑制RAEC衰老的作用,有明显的促进衰老的RAEC凋亡的作用。
This experiment had come from shandong provincial projects:topic Numbers--J05L05.
Objective:The recent studies indicate that, primary hypertension pertains to endothelial function obstacle. The ideal antihypertensive medication besides lower blood pressure, still should improve the structure and function of the vascular hypertension, reverse arterial remodeling, and make the function of normal, protect endothelial function and protection of target organs. The Uncaria rhynchOphylla is commonly used medicine for clinical treatment of hypertension. The effective components of the Uncaria rhynchOphylla total alkaloids have high biological activity, having good step-down, resisting myocardial reconstruction and antiarrhythmic effect, but the hypotensive mechanism is unclear. Previous research shows that, total alkaloids lower blood pressure through antihypertensive vascular remodeling, inhibit antihypertensive vascular smooth muscle cell proliferation. The field Inhibiting endothelial cell ageing step-down has not involved. Therefore, this research explored the function and mechanism of the Uncaria rhynchOphylla that antihypertensive vascular remodeling, inhibit endothelial cell aging. And try to open up its by inhibiting endothelial cell senescence-to protect endothelial cell function-reverse the vascular remodeling-lower blood pressure-protect the target organs, an effective way to control the field of hypertension.
Methods:In vivo experiments, we took spontaneously hypertensive rats (SHR) as a model. Then we observed the influence of Uncaria alkaloids on the blood pressure of SHR tail artery, on the rat thoracic aorta, mesenteric artery histological and stereological changes, on the rat aorta endothelial ultrastructure, on the Rat aortic endothelialβ-galactosidase expression and telomerase activity expression of the relative. On this basis, we study the effect and possible mechanism of Uncaria rhynchOphylla total alkaloids step-down, improve the effect of vascular remodeling. In vitro experiments, we build RAEC model AngⅡinduced by the proliferation and D-galacitiol induced agingl respectively. We observed the effects of total alkaloid on RAEC proliferation activity by MTT method, on RAEC Ca2+concentration the value of the relative expression by immunohistochemistry, on RAEC group cell cycle By flow cytometry, on RAEC ultrastructure by scanning electron microscopy,on positive rate of aging RAEC byβ-galactosidase staining, on the expression of telomerase activity in RAEC by PCR-ELISA assay and on the apoptosis of aging RAEC. To study the effect and the possible mechanism of Uncaria rhynchOphylla total alkaloids that AngⅡRAEC induced by inhibiting proliferation, restrain D-galacitiol RAEC induced aging and promote aging RAEC apoptosis.
Results:The vivo experiments show that RTA can reduce the total alkaloid SHR tail arterial blood pressure and has very obvious difference compared with the model group(P<0.01). Comparing with the model group, the RTA group, mesenteric artery and the thoracic aorta film thickness/lumen diameter ratio reduced significantly(P<0.05). The results of thoracic aortic endothelial scanning electron microscope shows that the RTA group s endothelial form structure were obviously improvedCompared comparing with the model group. It performances that endothelial cells aligned with a smooth surface, the cell shedding reduced obviously and lining damage ligtening obviously. The thoracic aortic endothelial rats beta galacitiol nucleoside enzyme expression of the RTA group reduced significantly compareing with the model group (P <0.05). AT the same time, the thoracic aortic endothelial rats relative express telomerase activity of the RTA group reduced significantly compareing too with the model group (P<0.05). The vitro experiments indicate that:The MTT experiments showed thatⅡangiotensin significantly promote RAEC proliferation, the Total alkaloid can inhibit the proliferation of angiotensinⅡ-induced RAEC, the RAEC Ca2+concentration of the RTA group significantly reduce relative to express (P<0.05), It was found that G1 period became high (P<0.05) and S period became lower (P<0.01) in the RTA group, and the RTA blocked the transform from G0/G1 period to synthesis of DNA period, so that theRAEC proliferation was inhibited. RAEC ultrastructure scanning electrometry microscopy showed that the RAEC morphological structure of the RTA group improved obviously, such as the cell morphology and size and microvilli quantity and distribution. Beta galacitiol nucleoside enzymes stain shows that D-galacitiol has obvious effect of RAEC induced aging, the rate of senescent cells of the RTA group reduced obviously (P<0.01). Detection of telomerase activity were significantly lower compareing with the model group (P<0.05). The RTA can improve senescence endothelial cell apoptosis significantly(P<0.05).
Conclusion:This medicine opened a new field for traditional Chinese medicine to control of hypertension,though the effective way that inhibitting endothelial cells-protecting endothelial function-reversing vascular remodeling-reducing blood pressure-protecting target organs. Research shows that RTA can significantly reduce the total alkaloid SHR tail arterial blood pressure.It has an significant function to lower blood pressure. The RTA has the obvious improvement, vascular remodeling of reverse hypertension. It can improve sendothelial function and structure and protect endothelial function and inhibit endothelial function of aging significantly. The RTA can inhibit Ang II RAEC proliferation-promoting effect. For D-galacitiol mediated RAEC aging has obvious inhibition. The RTA can obviously improve the structure and function of the RAEC. The RTA can reduce positive senescent cells and the telomerase activity. The RTA can inhibit the RAEC aging significantly. The RTA can improve senescence endothelial cell apoptosis significantly.
引文
[1]D'zan VJ, GibbonsGH, MorishitaR, et al. New perspectivesin hypertensien research. Potentials of vascular hiology. [J] Hepertens,1994,23:1132
[2]Oparil S, Zarnon MA, Calhoum DA. Pathogensis of hypertension[J], Annals of Internal Medicine,2003, 139(9):761-766
[3]Graham DL. Morphologic changes during hypertension. Am J Cardiol,1989,63:6c-9c
[4]刘 云邓世雄.血管病变在高血压发病机制中的作用.中国临床医药实用杂志,[J]2005,04(29)：58-60
[5]Howard DS, Sesso MP Bufing SC, et al. C-Reactive protein and the risk of develping Hypertension. JAMA,2003,290(22):2293-3005
[6]Georges JL, Louraci v, Poirier O, et al.Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction:the ECTIM study. J M01 Med,2001,79:300-305
[7]薛冰丁东新顾平生等.老年高血压患者血清TNF-a、IL-6的变化及其临床意义[J].放射免疫学杂志,2004,17(4)：270-271
[8]田心王蓓等,以自发性高血压大鼠为模型对高血压发病机制的研究[J].中华中医学杂志,2009,33(4)：112-114
[9]Dendorfer A, Dominiak P, Schunkert H. ACE inhibitors and angiotensin II receptor antagonists[J]. Handb Exp Pharmacol,2005,170:407-442
[10]王先梅杨丽霞.原发性高血压发病机制的研究进展.西南国防医药,2005,15(1)：98-100
[11]苏诚坚.高血压血管重塑发病机理及治疗对策.广东医学,1999,20(7)：485
[12]Dzau VJ, Gibbons GH, Morishita R, Pratt RE. New perspectives in hypertention research:potentials of vascular biology. Hypertention,1994,23 (6 Pt 2):132-140
[13]Langille BL.Blood flow-induced remodeling of the artery wall.In Bevan JA,Kaley G,Rubanyi G,eds:Flow-Dependent regulation of vascular function.New,York NY:Oxford,1995,277-299
[14]Greene AS.Tonellato PJ.Lui J,Lombard JH,Cowley AM Jr.Microvascular rarefaction and tissue vascular resistancein hypertension.AmJ Physiol,1989,256(12):126-131.
[15]Dimmeler S,Assmus B,Hermann C,Haendeler J,Zeiher AM.Fluid shear stess stimulates phosphorylation of Aki in human endothelial cells:involvement suppression of apoptosis. Circ Res,1998,83(3):334-341
[16]Krieger JE,Dzau VJ.Molecular biology of hypertension. Hypertension,1991,18(3):13-17
[17]Skalak TC,Price RJ.The role of mechanical stresses in microvasular remodeling. Microcirculation, 1996,3(2):143-165.
[18]Colden-Stanfied M,Schilling W P,Ritchie AK,et al.Bradykin in induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells.Circ Res,1987;61:632.
[19]Dzau VJ,Gibbons GH.Vascular remodeling:Mechanisms and implication. J Cardiovasc Pharmacol,1993;21:81.
[20]Dzau VJ,Gibbons GH,Morishita R,Pratt RE.New perspectives in hypertention research:potentials of vascular biology. Hyptention,1994,23(6):132-140.
[21]Dzau VJ.Theodore cooper lecture:tissue angiotensin and pathobiology of vascular disease:a unifying hypothesis. Hypertension,2001,37(4):1047-1052
[22]Han Y,Runge MS,Brasier AR.Angiotensin Ⅱ induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors.Circ Res,1999, 84(6):695-703.
[23]Haller H,Drab M,Luft FC.The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic anfiopathy. Clin Nephrol,1996,46(4):246-255
[24]Kenneth MY.Fibronectin peptides, in cell migration and wound repair. J Clini Invest,2000,105(11):1507-1509.
[25]Brekken RA,Sage EH.SPARC,a matricelluar protein:at the crossroad of cell-matrix communication.Matrix Biol,2001,19(8):816-827
[26]Moskowitz DW. From pharmacogenomics to imp roved patient outcomes:angiotensin I Converting enzyme as an examp le. Diabetes Technol Ther,2002,4:519-532
[27]梁 德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[28]赵连友.一氧化氮与高血压.新医学,1999,(30)5：505-506
[29]Cantillo C, Panza jA. Impaired endothelial regulation of vascular tone in patientst 1 systemic arterial hypertension. Vase Med,1998,3(2):1383
[30]何华美汪海肖文彬.血管内皮细胞功能失调与高血压[J].国外医学药学分册,1999,26(2)：79-84
[31]杨 军董天崴王敬磊等.白介素-7与原发性高血压血管内皮生长因子的相关研究[J].心血管康复医学杂志,2008,6：538-541)
[32]Feletou M and Vanhoutte PM. Endothelial dysfunction:a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006,291(3):H985-H100
[33]Cuzzocreas, Mazzone, Dugol, et al. Superoxide:a key player in hypertension [J]. FASEB J,2004,18 (1): 94-101
[34]陈衍智赵翌李萍萍.细胞衰老与肿瘤.实用肿瘤学杂志,2009,23(3)：261-264
[35]DimriGP. What has senescence got to do with cancer[J]. Cancer Cell,2005,7(6):505-51
[36]李虹白小涓陈香美.血管衰老机理及检测指标的研究进展.中华医学杂志,2005,85(3)：212-214
[37]Pueyo ME, Gonzalez W, Nicoletti A, et al, Angiotensin Ⅱ stimulates endothelial vascular cell adhesion molecule—1 via nuclear factor—kappaB activation induced by intracelular oxidative slless [J]. Arterioscler Thromb Vasc Biol,2000,20(3):645—651
[38]丁月霞刘启才.Ang Ⅱ对血管内皮细胞表达粘附分子和释放NO的影响[J].中国民康医学,2007,19(2)：81-84
[39]DrogeW. Oxidative stress and aging. Adv Exp Med Biol,2003,543:191-200
[40]IzzoJLJr.Aging and systolic hypertension:cluster patterns and problem solving Strategies to answer the genetic riddle[J].Hypertension,2001,37(4):1067-1068
[41]谭浩李登清黄民主.高血压病患者淋巴细胞端粒酶活性的研究[J].实用预防医学,2005,12(1)：13-15
[42]CaoY,LiH,MuF T.etal.Telomerasea ctivationc auses vascular Smooth muscle Cell proliferationin genetic hypertension[J].FASEBJ,2002,16(1):96-98
[43]杨善民.自发高血压大鼠动脉组织端粒酶活性研究[J].厦门大学学报,1999,38(2)：315-322
[44]杨善民.成年SHR动脉平滑肌细胞端粒酶活性和周期蛋白D1的研究[J].细胞生物学杂志,2000,22(2)：75-78
[45]戴秋艳.p受体阻断剂在高血压治疗中的地位[J].世界临床药物,2009,30(10)：597-600
[46]王峰木牙提.p受体阻断剂在高血压治疗中的研究进展[J].心血管病学进展,2009,30(增刊)：45-47
[47]Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension[J]. Hypertension, 2004,43(2):169-175
[48]Wood JM, Schnell CR, Cumin F, et al. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marm osets and spontaneously hypertensive rats [J]. Hypertens,2005,23:417-426
[49]Higashi Y, Sasaki S, Nakagawa K, et al. Tetrahydrobiopterin enhances forearm vascular response to acetylcbo line in both normotensivand hypertensive individuals[J]. Am J Hypertens,2002,15(4):326-332
[50]Hong HJ, Hsiao G, Cheng TH, et al. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontanesously hypertensive rats[J]. Hypertension,2001,38(5):1044-1048
[51]赵洪庆.高血压的中医治疗优势与不足[J].中华中西医学杂志,2009,7(2)：38-39
[52]Suk K,Kim SY,Leem K,et al. Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats[J]. life sciences,2002,70(21):2467-2480
[53]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28-29
[54]梁德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[55]林 蓉刘俊田甘伟杰等.川芎嗪对缺血缺糖状态下培养的血管内皮细胞ECV-304的影响[J].中国中药杂志,2004,29(5)：462-463
[56]张冀王韵汪炳华等.川芎嗪对花生四烯酸诱导血管内皮细胞凋亡的保护作用[J].中国临床康复,2003,7(30)：4066-4067
[57]徐东波张军平张文志等.丹参注射液对血管内皮细胞氧化损伤保护作用的实验研究[J].天津医科大学学报,2001,7(1)：21-23
[58]赵燕, 尹毅, 吕晓菊等.丹参对内毒素血症早期中性粒细胞(PMN)与内皮细胞(EC)黏附作用的影响[J].四川大学学报(医学版),2004,35(3)：320-322；346
[59]绪广林钱之玉.西红花甙对血管内皮细胞的保护作用研究[J].中草药,2002,33(5)：439442
[60]曹维娟何靖康.姜黄素对缺氧再给氧大鼠心脏微血管内皮细胞ICAM-1表达的影响[J].中国血液流变学杂志,2002,12(4)：295-297
[61]林桂珍林国生.大蒜素对血管内皮细胞脂质过氧化损伤的保护作用[J].微循环学杂志,2001,11(4)：5-6
[62]谭海彦朱 莉邢之华等.天麻钩藤饮改善高血压患者内皮功能的机理研究[J].山东医药,2005,45(1)：12-13
[63]张旭张超英.六味地黄丸药物血清对细胞内皮细胞内钙离子的影响[J].中药药理与临床,2003,19(5)：1-5
[64]卞慧敏张 旭.六味地黄汤药物血清抗血管内皮细胞凋亡的作用[J].中药药理与临床,2002,18(5)：9-11
[65]金明华吴伟康秦鉴等.四逆汤抗血管内皮脂质过氧化损伤作用[J].中国临床康复,2003,7(15)：2164-2165
[66]方素萍邱全瑛.黄连解毒汤含药血清对LPS／TNF-α诱导的人中性粒细胞与血管内皮细胞间的黏附影响[J].中国实验方剂学杂志,2001,7(2)：31-33
[67]郭来丁书文.复方莶草合剂抗动脉粥样硬化内皮细胞损伤实验研究[J].中医药学刊,2001,20(2)：105-107
[68]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响[J].湖北中医杂志,2003,25(7)：10-12
[69]徐灵建王文云.活血化瘀法对心脏X综合征患者内皮素1及血管内皮依赖性舒张功能的影响[J].中成药,2002,25(7)：519-521
[70]王瑞俭孙广仁孙宝民.钩藤碱提取工艺研究[J].吉林林学院学报,1998,14(2)：1090
[71]宋纯清,樊懿,黄伟晖,等.钩藤中不同成分降压作用的差异[J].中草药,2000,31(10)：762-764
[72]王盟.钩藤总生物碱的研究进展[J],实用医药杂志,2008,25(03)：360-362
[73]宋纯清樊懿黄伟晖等.钩藤中不同成分降压作用的差异[J].中草药,2000,31(10)：762-764
[74]余俊先谢笑龙吴芹等.异钩藤碱在麻醉猫的心血管药理效应与血药浓度的关系[J].四川生理科学杂志,2001,23(3)：123
[75]黄彬吴芹文国容等.血浆异钩藤碱浓度对大鼠血压和心脏收缩性能的影响[J].遵义医学院学报,2000,23(4)：299-300
[76]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28-29
[77]徐惠波史艳宇等.复方钩藤片降压、降脂作用的实验研究[J].中国中医药科技,2008,15(3)：182-183
[78]黄燮南吴芹石京山.钩藤碱和异钩藤碱对大鼠肠系膜血管和尾动脉收缩反应的影响[J].遵义医学院学报,1994,17(1)：7-10
[79]张志民张靖华余秀瑾.天麻钩藤饮治疗高血压病100例临床观察[J].中医药临床杂志.2005,10(17)：265
[80]马振峰李福民.天麻钩藤饮治疗高血压眩晕317例[J].中医函授通讯,1995,(5)：36-37
[81]杨庆有.天麻钩藤饮对原发性高血压患者TGF.p1、Bcl.2浓度的影响及临床意义探讨[J].中医研究,2006,19(7)：24-26
[82]谭海彦,邢之华,刘卫平,等·天麻钩藤饮对高血压病患者血压及血清GSH-PX的影响[J].湖南中医学院学报,2004,10(24)：38-39
[83]郭立芳白海燕陈国会.钩藤决明方治疗肝阳上亢型高血病32例[J].陕西中医,2007,28(2)：157
[84]孙敬方.动物实验方法学[M].北京：人民卫生出版社.第1版,2001：105
[85]张晓天.心脑喜康对自发性高血压大鼠血浆内皮素的影响.新疆中医药,1997,15(3)：34-35
[86]王向宇吴可贵晋学庆.卡托普利抑制自发性高血压大鼠血管平滑肌细胞增殖的机制[J].中华内科杂志,1997,36(9)：617-619
[87]张廷星苏津自芮红兵等.卡托普利对自发性高血压大鼠心血管重塑的影响[J].福建医科大学学报,2001,9,35(3)：250-252
[88]郑杨迟宝荣佟倩.高血压患者动脉结构和功能的变化[J].吉林大学学报(医学版),2005,31(2)：299-302
[89]Hayashi T, Nakayama Y, Tsumura K, et al. Reflection in the arteria-1 system and the risk of coronary heart disease. Am J 1998,25:174-178
[90]Liao D F. JenniferL. Duff:Guenter Daum, et al. Angiotensin II Stim-uIates MAP, Kinase Activity in Vascular Smooth Muscle Cells:Roleof Roaf. Cir Res,1996,79:1007-1014
[91]秦旭平廖端芳李元建.血管平滑肌细胞增殖及其调控[J].中国动脉硬化杂志,2001,9(5)：450-454
[92]Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis; role of telomere in endothelial dysfunction [J].Circulation,2002,105:541-544
[93]崔美芝刘浩李春艳.衰老动物模型的建立及评价[J].中国比较医学杂志,2006,16(2)：118-121
[94]王琳丁秀云刘谟焓等.D—乳糖对幼鼠心肌细胞拟衰老作用的实验[J].中国临床康复,2005,9(39)：25-27
[95]贾红杰张维东贾青,等.D一半乳糖诱导衰老高黏滞血症大鼠模型初探[J].中国微循环,2004；8(1)：39-42
[96]Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progress:new therapeutic target for vascular proliferatin disease[J].Circulation,1998,98(1):82-89
[1]Suk K,Kim SY,Leem K,et al. Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats. life sciences,2002,70(21):2467-2480
[2]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28。29
[3]梁 德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[4]林蓉刘俊田甘伟杰等.川芎嗪对缺血缺糖状态下培养的血管内皮细胞ECV-304的影响[J].中国中药杂志,2004,29(5)：462-463
[5]张冀王韵汪炳华等.川芎嗪对花生四烯酸诱导血管内皮细胞凋亡的保护作用[J].中国临床康复,2003,7(30)：4066-4067
[6]徐东波张军平张文志等.丹参注射液对血管内皮细胞氧化损伤保护作用的实验研究[J].天津医科大学学报,2001,7(1)：21-23
[7]赵燕, 尹毅, 吕晓菊等.丹参对内毒素血症早期中性粒细胞(PMN)与内皮细胞(EC)黏附作用的影响[J].四川大学学报(医学版),2004,35(3)：320-322；346
[8]绪广林钱之玉.西红花甙对血管内皮细胞的保护作用研究[J].中草药,2002,33(5)：439-442
[9]曹维娟何靖康.姜黄素对缺氧再给氧大鼠心脏微血管内皮细胞ICAM-1表达的影响[J].中国血液流变学杂志,2002,12(4)：295-297
[10]林桂珍林国生.大蒜素对血管内皮细胞脂质过氧化损伤的保护作用[J].微循环学杂志,2001,11(4)：5-6
[11]谭海彦 朱莉 邢之华等.天麻钩藤饮改善高血压患者内皮功能的机理研究[J].山东医药,2005,45(1)：12-13
[12]张旭张超英.六昧地黄丸药物血清对细胞内皮细胞内钙离子的影响[J].中药药理与临床,2003,19(5)：1-5
[13]卞慧敏 张 旭.六味地黄汤药物血清抗血管内皮细胞凋亡的作用[J].中药药理与临床,2002,18(5)：9-11
[14]金明华吴伟康秦鉴等.四逆汤抗血管内皮脂质过氧化损伤作用[J].中国临床康复,2003,7(15)：2164-2165
[15]方素萍邱全瑛.黄连解毒汤含药血清对LPS/TNF-α诱导的人中性粒细胞与血管内皮细胞间的黏附影响[J].中国实验方剂学杂志,2001,7(2)：31-33
[16]郭来丁书文.复方莶草合剂抗动脉粥样硬化内皮细胞损伤实验研究[J].中医药学刊,2001,20(2)：105-107
[17]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响[J].湖北中医杂志,2003,25(7)：10-12
[18]徐灵建王文云.活血化瘀法对心脏X综合征患者内皮素1及血管内皮依赖性舒张功能的影响[J].中成药,2002,25(7)：519-521
[19]韩鹏程.原发性高血压的治疗体会[J].中外医疗,2008,(27)：48
[20]吴世才.中医治疗原发性高血137例的体会[J].海南医学院学报,2009,15(11)：1433-1435
[2]Oparil S, Zarnon MA, Calhoum DA. Pathogensis of hypertension[J], Annals of Internal Medicine,2003, 139(9):761-766
[3]Graham DL. Morphologic changes during hypertension. Am J Cardiol,1989,63:6c-9c
[4]刘 云邓世雄.血管病变在高血压发病机制中的作用.中国临床医药实用杂志,[J]2005,04(29)：58-60
[5]Howard DS, Sesso MP Bufing SC, et al. C-Reactive protein and the risk of develping Hypertension. JAMA,2003,290(22):2293-3005
[6]Georges JL, Louraci v, Poirier O, et al.Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction:the ECTIM study. J M01 Med,2001,79:300-305
[7]薛冰丁东新顾平生等.老年高血压患者血清TNF-a、IL-6的变化及其临床意义[J].放射免疫学杂志,2004,17(4)：270-271
[8]田心王蓓等,以自发性高血压大鼠为模型对高血压发病机制的研究[J].中华中医学杂志,2009,33(4)：112-114
[9]Dendorfer A, Dominiak P, Schunkert H. ACE inhibitors and angiotensin II receptor antagonists[J]. Handb Exp Pharmacol,2005,170:407-442
[10]王先梅杨丽霞.原发性高血压发病机制的研究进展.西南国防医药,2005,15(1)：98-100
[11]苏诚坚.高血压血管重塑发病机理及治疗对策.广东医学,1999,20(7)：485
[12]Dzau VJ, Gibbons GH, Morishita R, Pratt RE. New perspectives in hypertention research:potentials of vascular biology. Hypertention,1994,23 (6 Pt 2):132-140
[13]Langille BL.Blood flow-induced remodeling of the artery wall.In Bevan JA,Kaley G,Rubanyi G,eds:Flow-Dependent regulation of vascular function.New,York NY:Oxford,1995,277-299
[14]Greene AS.Tonellato PJ.Lui J,Lombard JH,Cowley AM Jr.Microvascular rarefaction and tissue vascular resistancein hypertension.AmJ Physiol,1989,256(12):126-131.
[15]Dimmeler S,Assmus B,Hermann C,Haendeler J,Zeiher AM.Fluid shear stess stimulates phosphorylation of Aki in human endothelial cells:involvement suppression of apoptosis. Circ Res,1998,83(3):334-341
[16]Krieger JE,Dzau VJ.Molecular biology of hypertension. Hypertension,1991,18(3):13-17
[17]Skalak TC,Price RJ.The role of mechanical stresses in microvasular remodeling. Microcirculation, 1996,3(2):143-165.
[18]Colden-Stanfied M,Schilling W P,Ritchie AK,et al.Bradykin in induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells.Circ Res,1987;61:632.
[19]Dzau VJ,Gibbons GH.Vascular remodeling:Mechanisms and implication. J Cardiovasc Pharmacol,1993;21:81.
[20]Dzau VJ,Gibbons GH,Morishita R,Pratt RE.New perspectives in hypertention research:potentials of vascular biology. Hyptention,1994,23(6):132-140.
[21]Dzau VJ.Theodore cooper lecture:tissue angiotensin and pathobiology of vascular disease:a unifying hypothesis. Hypertension,2001,37(4):1047-1052
[22]Han Y,Runge MS,Brasier AR.Angiotensin Ⅱ induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors.Circ Res,1999, 84(6):695-703.
[23]Haller H,Drab M,Luft FC.The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic anfiopathy. Clin Nephrol,1996,46(4):246-255
[24]Kenneth MY.Fibronectin peptides, in cell migration and wound repair. J Clini Invest,2000,105(11):1507-1509.
[25]Brekken RA,Sage EH.SPARC,a matricelluar protein:at the crossroad of cell-matrix communication.Matrix Biol,2001,19(8):816-827
[26]Moskowitz DW. From pharmacogenomics to imp roved patient outcomes:angiotensin I Converting enzyme as an examp le. Diabetes Technol Ther,2002,4:519-532
[27]梁 德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[28]赵连友.一氧化氮与高血压.新医学,1999,(30)5：505-506
[29]Cantillo C, Panza jA. Impaired endothelial regulation of vascular tone in patientst 1 systemic arterial hypertension. Vase Med,1998,3(2):1383
[30]何华美汪海肖文彬.血管内皮细胞功能失调与高血压[J].国外医学药学分册,1999,26(2)：79-84
[31]杨 军董天崴王敬磊等.白介素-7与原发性高血压血管内皮生长因子的相关研究[J].心血管康复医学杂志,2008,6：538-541)
[32]Feletou M and Vanhoutte PM. Endothelial dysfunction:a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006,291(3):H985-H100
[33]Cuzzocreas, Mazzone, Dugol, et al. Superoxide:a key player in hypertension [J]. FASEB J,2004,18 (1): 94-101
[34]陈衍智赵翌李萍萍.细胞衰老与肿瘤.实用肿瘤学杂志,2009,23(3)：261-264
[35]DimriGP. What has senescence got to do with cancer[J]. Cancer Cell,2005,7(6):505-51
[36]李虹白小涓陈香美.血管衰老机理及检测指标的研究进展.中华医学杂志,2005,85(3)：212-214
[37]Pueyo ME, Gonzalez W, Nicoletti A, et al, Angiotensin Ⅱ stimulates endothelial vascular cell adhesion molecule—1 via nuclear factor—kappaB activation induced by intracelular oxidative slless [J]. Arterioscler Thromb Vasc Biol,2000,20(3):645—651
[38]丁月霞刘启才.Ang Ⅱ对血管内皮细胞表达粘附分子和释放NO的影响[J].中国民康医学,2007,19(2)：81-84
[39]DrogeW. Oxidative stress and aging. Adv Exp Med Biol,2003,543:191-200
[40]IzzoJLJr.Aging and systolic hypertension:cluster patterns and problem solving Strategies to answer the genetic riddle[J].Hypertension,2001,37(4):1067-1068
[41]谭浩李登清黄民主.高血压病患者淋巴细胞端粒酶活性的研究[J].实用预防医学,2005,12(1)：13-15
[42]CaoY,LiH,MuF T.etal.Telomerasea ctivationc auses vascular Smooth muscle Cell proliferationin genetic hypertension[J].FASEBJ,2002,16(1):96-98
[43]杨善民.自发高血压大鼠动脉组织端粒酶活性研究[J].厦门大学学报,1999,38(2)：315-322
[44]杨善民.成年SHR动脉平滑肌细胞端粒酶活性和周期蛋白D1的研究[J].细胞生物学杂志,2000,22(2)：75-78
[45]戴秋艳.p受体阻断剂在高血压治疗中的地位[J].世界临床药物,2009,30(10)：597-600
[46]王峰木牙提.p受体阻断剂在高血压治疗中的研究进展[J].心血管病学进展,2009,30(增刊)：45-47
[47]Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension[J]. Hypertension, 2004,43(2):169-175
[48]Wood JM, Schnell CR, Cumin F, et al. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marm osets and spontaneously hypertensive rats [J]. Hypertens,2005,23:417-426
[49]Higashi Y, Sasaki S, Nakagawa K, et al. Tetrahydrobiopterin enhances forearm vascular response to acetylcbo line in both normotensivand hypertensive individuals[J]. Am J Hypertens,2002,15(4):326-332
[50]Hong HJ, Hsiao G, Cheng TH, et al. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontanesously hypertensive rats[J]. Hypertension,2001,38(5):1044-1048
[51]赵洪庆.高血压的中医治疗优势与不足[J].中华中西医学杂志,2009,7(2)：38-39
[52]Suk K,Kim SY,Leem K,et al. Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats[J]. life sciences,2002,70(21):2467-2480
[53]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28-29
[54]梁德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[55]林 蓉刘俊田甘伟杰等.川芎嗪对缺血缺糖状态下培养的血管内皮细胞ECV-304的影响[J].中国中药杂志,2004,29(5)：462-463
[56]张冀王韵汪炳华等.川芎嗪对花生四烯酸诱导血管内皮细胞凋亡的保护作用[J].中国临床康复,2003,7(30)：4066-4067
[57]徐东波张军平张文志等.丹参注射液对血管内皮细胞氧化损伤保护作用的实验研究[J].天津医科大学学报,2001,7(1)：21-23
[58]赵燕, 尹毅, 吕晓菊等.丹参对内毒素血症早期中性粒细胞(PMN)与内皮细胞(EC)黏附作用的影响[J].四川大学学报(医学版),2004,35(3)：320-322；346
[59]绪广林钱之玉.西红花甙对血管内皮细胞的保护作用研究[J].中草药,2002,33(5)：439442
[60]曹维娟何靖康.姜黄素对缺氧再给氧大鼠心脏微血管内皮细胞ICAM-1表达的影响[J].中国血液流变学杂志,2002,12(4)：295-297
[61]林桂珍林国生.大蒜素对血管内皮细胞脂质过氧化损伤的保护作用[J].微循环学杂志,2001,11(4)：5-6
[62]谭海彦朱 莉邢之华等.天麻钩藤饮改善高血压患者内皮功能的机理研究[J].山东医药,2005,45(1)：12-13
[63]张旭张超英.六味地黄丸药物血清对细胞内皮细胞内钙离子的影响[J].中药药理与临床,2003,19(5)：1-5
[64]卞慧敏张 旭.六味地黄汤药物血清抗血管内皮细胞凋亡的作用[J].中药药理与临床,2002,18(5)：9-11
[65]金明华吴伟康秦鉴等.四逆汤抗血管内皮脂质过氧化损伤作用[J].中国临床康复,2003,7(15)：2164-2165
[66]方素萍邱全瑛.黄连解毒汤含药血清对LPS／TNF-α诱导的人中性粒细胞与血管内皮细胞间的黏附影响[J].中国实验方剂学杂志,2001,7(2)：31-33
[67]郭来丁书文.复方莶草合剂抗动脉粥样硬化内皮细胞损伤实验研究[J].中医药学刊,2001,20(2)：105-107
[68]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响[J].湖北中医杂志,2003,25(7)：10-12
[69]徐灵建王文云.活血化瘀法对心脏X综合征患者内皮素1及血管内皮依赖性舒张功能的影响[J].中成药,2002,25(7)：519-521
[70]王瑞俭孙广仁孙宝民.钩藤碱提取工艺研究[J].吉林林学院学报,1998,14(2)：1090
[71]宋纯清,樊懿,黄伟晖,等.钩藤中不同成分降压作用的差异[J].中草药,2000,31(10)：762-764
[72]王盟.钩藤总生物碱的研究进展[J],实用医药杂志,2008,25(03)：360-362
[73]宋纯清樊懿黄伟晖等.钩藤中不同成分降压作用的差异[J].中草药,2000,31(10)：762-764
[74]余俊先谢笑龙吴芹等.异钩藤碱在麻醉猫的心血管药理效应与血药浓度的关系[J].四川生理科学杂志,2001,23(3)：123
[75]黄彬吴芹文国容等.血浆异钩藤碱浓度对大鼠血压和心脏收缩性能的影响[J].遵义医学院学报,2000,23(4)：299-300
[76]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28-29
[77]徐惠波史艳宇等.复方钩藤片降压、降脂作用的实验研究[J].中国中医药科技,2008,15(3)：182-183
[78]黄燮南吴芹石京山.钩藤碱和异钩藤碱对大鼠肠系膜血管和尾动脉收缩反应的影响[J].遵义医学院学报,1994,17(1)：7-10
[79]张志民张靖华余秀瑾.天麻钩藤饮治疗高血压病100例临床观察[J].中医药临床杂志.2005,10(17)：265
[80]马振峰李福民.天麻钩藤饮治疗高血压眩晕317例[J].中医函授通讯,1995,(5)：36-37
[81]杨庆有.天麻钩藤饮对原发性高血压患者TGF.p1、Bcl.2浓度的影响及临床意义探讨[J].中医研究,2006,19(7)：24-26
[82]谭海彦,邢之华,刘卫平,等·天麻钩藤饮对高血压病患者血压及血清GSH-PX的影响[J].湖南中医学院学报,2004,10(24)：38-39
[83]郭立芳白海燕陈国会.钩藤决明方治疗肝阳上亢型高血病32例[J].陕西中医,2007,28(2)：157
[84]孙敬方.动物实验方法学[M].北京：人民卫生出版社.第1版,2001：105
[85]张晓天.心脑喜康对自发性高血压大鼠血浆内皮素的影响.新疆中医药,1997,15(3)：34-35
[86]王向宇吴可贵晋学庆.卡托普利抑制自发性高血压大鼠血管平滑肌细胞增殖的机制[J].中华内科杂志,1997,36(9)：617-619
[87]张廷星苏津自芮红兵等.卡托普利对自发性高血压大鼠心血管重塑的影响[J].福建医科大学学报,2001,9,35(3)：250-252
[88]郑杨迟宝荣佟倩.高血压患者动脉结构和功能的变化[J].吉林大学学报(医学版),2005,31(2)：299-302
[89]Hayashi T, Nakayama Y, Tsumura K, et al. Reflection in the arteria-1 system and the risk of coronary heart disease. Am J 1998,25:174-178
[90]Liao D F. JenniferL. Duff:Guenter Daum, et al. Angiotensin II Stim-uIates MAP, Kinase Activity in Vascular Smooth Muscle Cells:Roleof Roaf. Cir Res,1996,79:1007-1014
[91]秦旭平廖端芳李元建.血管平滑肌细胞增殖及其调控[J].中国动脉硬化杂志,2001,9(5)：450-454
[92]Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis; role of telomere in endothelial dysfunction [J].Circulation,2002,105:541-544
[93]崔美芝刘浩李春艳.衰老动物模型的建立及评价[J].中国比较医学杂志,2006,16(2)：118-121
[94]王琳丁秀云刘谟焓等.D—乳糖对幼鼠心肌细胞拟衰老作用的实验[J].中国临床康复,2005,9(39)：25-27
[95]贾红杰张维东贾青,等.D一半乳糖诱导衰老高黏滞血症大鼠模型初探[J].中国微循环,2004；8(1)：39-42
[96]Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progress:new therapeutic target for vascular proliferatin disease[J].Circulation,1998,98(1):82-89
[1]Suk K,Kim SY,Leem K,et al. Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats. life sciences,2002,70(21):2467-2480
[2]怡悦.钩藤对自发性高血压大鼠血管内皮功能的影响[J].国外医学·中医中药分册,2000,22(1)：28。29
[3]梁 德姚珍松杨志东等.川芎嗪对家兔血管内皮细胞修复的影响[J].广州中医药大学学报,2001,18(2)：155-158
[4]林蓉刘俊田甘伟杰等.川芎嗪对缺血缺糖状态下培养的血管内皮细胞ECV-304的影响[J].中国中药杂志,2004,29(5)：462-463
[5]张冀王韵汪炳华等.川芎嗪对花生四烯酸诱导血管内皮细胞凋亡的保护作用[J].中国临床康复,2003,7(30)：4066-4067
[6]徐东波张军平张文志等.丹参注射液对血管内皮细胞氧化损伤保护作用的实验研究[J].天津医科大学学报,2001,7(1)：21-23
[7]赵燕, 尹毅, 吕晓菊等.丹参对内毒素血症早期中性粒细胞(PMN)与内皮细胞(EC)黏附作用的影响[J].四川大学学报(医学版),2004,35(3)：320-322；346
[8]绪广林钱之玉.西红花甙对血管内皮细胞的保护作用研究[J].中草药,2002,33(5)：439-442
[9]曹维娟何靖康.姜黄素对缺氧再给氧大鼠心脏微血管内皮细胞ICAM-1表达的影响[J].中国血液流变学杂志,2002,12(4)：295-297
[10]林桂珍林国生.大蒜素对血管内皮细胞脂质过氧化损伤的保护作用[J].微循环学杂志,2001,11(4)：5-6
[11]谭海彦 朱莉 邢之华等.天麻钩藤饮改善高血压患者内皮功能的机理研究[J].山东医药,2005,45(1)：12-13
[12]张旭张超英.六昧地黄丸药物血清对细胞内皮细胞内钙离子的影响[J].中药药理与临床,2003,19(5)：1-5
[13]卞慧敏 张 旭.六味地黄汤药物血清抗血管内皮细胞凋亡的作用[J].中药药理与临床,2002,18(5)：9-11
[14]金明华吴伟康秦鉴等.四逆汤抗血管内皮脂质过氧化损伤作用[J].中国临床康复,2003,7(15)：2164-2165
[15]方素萍邱全瑛.黄连解毒汤含药血清对LPS/TNF-α诱导的人中性粒细胞与血管内皮细胞间的黏附影响[J].中国实验方剂学杂志,2001,7(2)：31-33
[16]郭来丁书文.复方莶草合剂抗动脉粥样硬化内皮细胞损伤实验研究[J].中医药学刊,2001,20(2)：105-107
[17]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响[J].湖北中医杂志,2003,25(7)：10-12
[18]徐灵建王文云.活血化瘀法对心脏X综合征患者内皮素1及血管内皮依赖性舒张功能的影响[J].中成药,2002,25(7)：519-521
[19]韩鹏程.原发性高血压的治疗体会[J].中外医疗,2008,(27)：48
[20]吴世才.中医治疗原发性高血137例的体会[J].海南医学院学报,2009,15(11)：1433-1435
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |